Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever
- PMID: 2295861
- DOI: 10.1093/infdis/161.1.79
Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever
Abstract
Interleukins (IL) -1 beta and -1 alpha and tumor necrosis factor (TNF-alpha) were measured by radioimmunoassay in plasma samples from 44 healthy individuals, 15 patients in septic shock, and 6 volunteers infused with endotoxin. Plasma IL-1 alpha levels were low (40 pg/ml) or undetectable in all situations. In 67% of the healthy subjects, plasma IL-1 beta levels were less than 70 pg/ml. Septic patients had higher plasma IL-1 beta levels (120 +/- 17 pg/ml, P = .001); those of surviving patients were higher than those of patients who died (P = .05). Plasma TNF-alpha concentrations in septic individuals were elevated (119 +/- 30 pg/ml) and correlated with severity of illness (r = .73, P = .003), but no correlation was observed between plasma IL-1 beta and TNF-alpha concentrations in individual samples. Infusion of endotoxin caused a twofold elevation of IL-1 beta, from a baseline of 35 +/- 5 pg/ml to a maximum of 69 +/- 27 pg/ml at 180 min (P less than .05). Peak TNF-alpha levels after endotoxin infusion were 15 times higher than IL-1 beta levels, were attained more rapidly (90 min), and as with the septic patients, did not correlate with IL-1 beta levels. These data support the concept that plasma IL-1 beta and TNF-alpha concentrations are regulated independently and are associated with different clinical outcomes.
Similar articles
-
Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome.Ann Intern Med. 1993 Oct 15;119(8):771-8. doi: 10.7326/0003-4819-119-8-199310150-00001. Ann Intern Med. 1993. PMID: 8379598
-
Two types of septic shock classified by the plasma levels of cytokines and endotoxin.Circ Shock. 1992 Dec;38(4):264-74. Circ Shock. 1992. PMID: 1292890
-
Inflammatory cytokine response in patients with septic shock secondary to generalized peritonitis.Crit Care Med. 2000 Feb;28(2):433-7. doi: 10.1097/00003246-200002000-00024. Crit Care Med. 2000. PMID: 10708179
-
Role of interleukin-10 in monocyte hyporesponsiveness associated with septic shock.Crit Care Med. 2001 Jan;29(1):129-33. doi: 10.1097/00003246-200101000-00026. Crit Care Med. 2001. PMID: 11176172 Clinical Trial.
-
Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma.Crit Care Med. 1997 Nov;25(11):1813-9. doi: 10.1097/00003246-199711000-00018. Crit Care Med. 1997. PMID: 9366763
Cited by
-
Monitoring of immunotherapy with cytokines or monoclonal antibodies.Cytotechnology. 1995 Jan;18(1-2):93-106. doi: 10.1007/BF00744324. Cytotechnology. 1995. PMID: 22358641
-
Use of immune modulators in nonspecific therapy of bacterial infections.Antimicrob Agents Chemother. 1992 Jan;36(1):1-5. doi: 10.1128/AAC.36.1.1. Antimicrob Agents Chemother. 1992. PMID: 1590674 Free PMC article. Review. No abstract available.
-
Effects of in vivo endotoxin infusions on in vitro cellular immune responses in humans.J Clin Immunol. 1992 Nov;12(6):440-50. doi: 10.1007/BF00918856. J Clin Immunol. 1992. PMID: 1287036
-
Endotoxaemia and serum tumour necrosis factor as prognostic markers in severe acute pancreatitis.Gut. 1992 Aug;33(8):1126-8. doi: 10.1136/gut.33.8.1126. Gut. 1992. PMID: 1398241 Free PMC article.
-
Lipopolysaccharide-tumor necrosis factor-glucocorticoid interactions during cecal ligation and puncture-induced sepsis in mature versus senescent mice.Infect Immun. 1992 Mar;60(3):976-82. doi: 10.1128/iai.60.3.976-982.1992. Infect Immun. 1992. PMID: 1541572 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical